Particle Metrix

frontier technology - cooperative spirit They both have many years of experience in the analysis of various micro- and nanoparticles.

Particle Metrix was founded in 2004 by the chemist Margret Böck and physicist Dr. Hanno Wachernig in Meerbusch near Dusseldorf. During the first two years, the company focused on counseling work for the particle characterization business. In 2006, Particle Metrix started developing its own nanoparticle
analyzers. Today, Particle Metrix's know-how comprises the development, production and sale of particle analysis devices using nanoparticle tracking technology. The company headquarter is nowadays located in Inning am Ammersee at the gates of Munich, and in addition to the administration and development department, also includes production as well as the service and support center. An experienced team of electrical engineers, chemists, biologists and physicists is available to the
customer to competently answer all possible questions. In addition to the large area of technical nanoparticles (e.g. colloidal and macromolecular solutions, emulsions, dispersions or nanobubbles), bio-medical and clinical applications play a central role for Particle Metrix. The company has specialized in the characterization of extracellular vesicles, exosomes, liposomes and viruses, using both scatter and fluorescence-based methods. The focus of
interest is on determining the size and concentration as well as measuring zeta potential of particles in the nanometer scale

24/02/2026

𝗣𝗮𝗿𝘁𝗶𝗰𝗹𝗲 𝗠𝗲𝘁𝗿𝗶𝘅 𝗶𝘀 𝗲𝘅𝗽𝗮𝗻𝗱𝗶𝗻𝗴 𝗶𝗻 𝗟𝗮𝘁𝗶𝗻 𝗔𝗺𝗲𝗿𝗶𝗰𝗮!

Particle Metrix is a global leader in advanced Nanoparticle Tracking Analysis ( ). To further strengthen our presence, we are seeking strategic distribution partners for our ZetaView® Evolution product line across Latin America and the Caribbean.
Target Regions:
▪️North America: 𝗠𝗲𝘅𝗶𝗰𝗼
▪️Central & South America: 𝗖𝗼𝘀𝘁𝗮 𝗥𝗶𝗰𝗮, 𝗘𝗹 𝗦𝗮𝗹𝘃𝗮𝗱𝗼𝗿, 𝗚𝘂𝗮𝘁𝗲𝗺𝗮𝗹𝗮, 𝗛𝗼𝗻𝗱𝘂𝗿𝗮𝘀, 𝗡𝗶𝗰𝗮𝗿𝗮𝗴𝘂𝗮, 𝗣𝗮𝗻𝗮𝗺𝗮, 𝗕𝗼𝗹𝗶𝘃𝗶𝗮, 𝗖𝗼𝗹𝗼𝗺𝗯𝗶𝗮, 𝗘𝗰𝘂𝗮𝗱𝗼𝗿, 𝗣𝗮𝗿𝗮𝗴𝘂𝗮𝘆, 𝗣𝗲𝗿𝘂, 𝗨𝗿𝘂𝗴𝘂𝗮𝘆
▪️The Caribbean: 𝗗𝗼𝗺𝗶𝗻𝗶𝗰𝗮𝗻 𝗥𝗲𝗽𝘂𝗯𝗹𝗶𝗰

Our cutting-edge technology sets the benchmark for the characterization of complex biological and synthetic nanoparticles in:
▪️𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲𝘀 & 𝗕𝗶𝗼𝘁𝗲𝗰𝗵: Extracellular Vesicles (EVs), Exosomes, and Viruses
▪️𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀: Lipid Nanoparticles (LNPs), Liposomes, and Nano-drug delivery systems
▪️𝗘𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁𝗮𝗹 𝗦𝗰𝗶𝗲𝗻𝗰𝗲𝘀
▪️𝗠𝗮𝘁𝗲𝗿𝗶𝗮𝗹𝘀 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵

What we are looking for:
✔ Proven track record in scientific or analytical instrumentation
✔ Strong technical service and after-sales support capabilities
✔ Established national coverage and access to key research and industrial sectors

What we offer:
✔ Market-leading NTA technology (Size, Concentration, Zeta Potential & Fluorescence)
✔ Specialized solutions for LNP and EV characterization
✔ Comprehensive technical/commercial training and direct manufacturer support
✔ Growth opportunities in a rapidly expanding high-tech market

𝗥𝗲𝗮𝗱𝘆 𝘁𝗼 𝗯𝗿𝗶𝗻𝗴 𝗮𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗻𝗮𝗻𝗼𝗽𝗮𝗿𝘁𝗶𝗰𝗹𝗲 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝘁𝗼 𝘆𝗼𝘂𝗿 𝗺𝗮𝗿𝗸𝗲𝘁?

📩 Contact us today to explore partnership opportunities and become an official of Particle Metrix GmbH in your region.
Let’s shape the future of together.
🔗 https://www.particle-metrix.com/pages/contact

18/02/2026

🔬 𝗣𝘂𝗯𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁 | 𝗭𝗲𝘁𝗮𝗩𝗶𝗲𝘄® 𝗤𝗨𝗔𝗧𝗧 | 𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝗼𝗿𝗴𝗮𝗻𝗲𝗹𝗹𝗲-𝘀𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗲𝘅𝘁𝗿𝗮𝗰𝗲𝗹𝗹𝘂𝗹𝗮𝗿 𝘃𝗲𝘀𝗶𝗰𝗹𝗲𝘀 𝗮𝘁 𝘁𝗵𝗲 𝘀𝗶𝗻𝗴𝗹𝗲-𝗽𝗮𝗿𝘁𝗶𝗰𝗹𝗲 𝗹𝗲𝘃𝗲𝗹

Extracellular vesicles ( ) are highly heterogeneous, and this diversity is closely linked to their biological origin and function. One particularly powerful approach to better resolve this heterogeneity is the use of organelle-specific fluorescent dyes, for example targeting the endoplasmic reticulum (ER) or mitochondria.
A recent study demonstrates that EV subpopulations labeled with such organelle-specific dyes can be detected and analyzed on a single-vesicle level using and nanoparticle tracking analysis.
ER-positive and mitochondria-positive EVs, as well as double-positive vesicles, can be identified, quantified, and characterized, providing new insights into EV biogenesis and intracellular trafficking pathways.

At Particle Metrix, we are excited to see that this level of organelle-specific EV detection is achievable with the ZetaView® platform.
The combination of:
· organelle-specific fluorescent dyes
· multi-laser fluorescence NTA
· and colocalization analysis
highlights the potential of advanced single-particle analytics to move beyond size and concentration and towards functional EV characterization, in both cell culture models and complex biological samples.
A great example of how innovative labeling strategies and advanced technology come together to deepen our understanding of EV biology.
🔗 https://www.particle-metrix.com/blogs/publications

17/02/2026

Day 1 at is complete. Thank you to everyone who attended Bertrand Damart’s talk on the ZetaView® Evolution and joined the discussion on nanoparticle characterization.

Today, Sonia Contarini ( ) and Bertrand (Particle Metrix) are at the joint booth and look forward to meeting visitors throughout the day.
Over the next two days, the program will continue with the workshop and live ZetaView® Evolution sessions, including demonstrations of the fluorescence capabilities using lyophilized EVs and antibodies.

We look forward to continuing the conversations here in Rome at the Conference and School on Extracellular Vesicles and Nanoparticles.
🔗 https://eventuallyevents.it/csevp_2026/

Università di Roma Tor Vergata

10/02/2026

𝗡𝗲𝘄 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗡𝗼𝘁𝗲 𝗿𝗲𝗹𝗲𝗮𝘀𝗲𝗱!

𝗔𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁 𝗼𝗳 𝗘𝘅𝘁𝗿𝗮𝗰𝗲𝗹𝗹𝘂𝗹𝗮𝗿 𝗩𝗲𝘀𝗶𝗰𝗹𝗲 𝗣𝘂𝗿𝗶𝘁𝘆 𝗨𝘀𝗶𝗻𝗴 𝗭𝗲𝘁𝗮𝗩𝗶𝗲𝘄® 𝗙𝗹𝘂𝗼𝗿𝗲𝘀𝗰𝗲𝗻𝗰𝗲 𝗡𝗧𝗔 (𝗙-𝗡𝗧𝗔) 𝗶𝗻 𝗖𝗼𝗺𝗽𝗮𝗿𝗶𝘀𝗼𝗻 𝘁𝗼 𝗙𝗹𝗼𝘄 𝗖𝘆𝘁𝗼𝗺𝗲𝘁𝗿𝘆 𝗮𝗻𝗱 𝗧𝗥𝗣𝗦

How pure are your extracellular vesicle (EV) samples?

Standard NTA measures particle and but does not intrinsically distinguish vesicular from non-vesicular particles.

In our new application note, we show how fluorescence (F-NTA) with the ZetaView® system enables quantitative differentiation between total particles and EV-specific using membrane dyes and tetraspanin labeling. The approach is benchmarked against flow cytometry and TRPS.

👉 Read how F-NTA improves your EV purity assessment.
https://www.particle-metrix.com/blogs/application-notes/assessment-of-extracellular-vesicle-purity-using-zetaview%C2%AE-fluorescence-nta-f-nta-in-comparison-to-flow-cytometry-and-trps

09/02/2026

𝗠𝗲𝗲𝘁 𝘂𝘀 𝗮𝘁 𝗖𝗦𝗘𝗩𝗣-𝟮𝟬𝟮𝟲 | 𝗥𝗼𝗺𝗲, 𝗜𝘁𝗮𝗹𝘆 | 𝗙𝗲𝗯𝗿𝘂𝗮𝗿𝘆 𝟭𝟲–𝟮𝟬, 𝟮𝟬𝟮𝟲

We are excited to announce that Particle Metrix will be a Diamond Plus Sponsor of the Conference and School on Extracellular Vesicles and Nanoparticles ( ), together with our distributor AMIRA.

Conference | Feb 16–17 | Frascati, Villa Tuscolana
• Feb 16 | 12:30 – 🎤 Bertrand DAMART – ZetaView® Evolution: A new edge for nanoparticle characterization
Visit us at our joint booth to get a first hands-on look at the ZetaView® Evolution, and learn how advanced and fluorescence capabilities can take EV and nanoparticle characterization to the next level.

School on EVs & Nanoparticles | Feb 18–20 | Università di Roma Tor Vergata
• Feb 18 | 12:15–12:45 – Theory on by NTA
• Feb 19 | 14:00–15:00 – Practical session at Bottini Lab
During the practical sessions, we will highlight the fluorescence capabilities of the ZetaView® Evolution, including live demonstrations using lyophilized EVs and antibodies.

We look forward to seeing you in Rome!

04/02/2026

🔬 𝗘𝗹𝗲𝘃𝗮𝘁𝗲 𝘆𝗼𝘂𝗿 𝗭𝗲𝘁𝗮𝗩𝗶𝗲𝘄® 𝘅𝟯𝟬 𝘁𝗼 𝗘𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗦𝗲𝗿𝗶𝗲𝘀 𝗽𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲

Keep your existing Particle Metrix ZetaView® system up to date – no need to invest in a new instrument. Powered by the latest ® software and a new, more sensitive camera, the ZetaView® x30 can now be upgraded to achieve performance levels comparable to the ZetaView® Evolution Series.
Benefit from current technology, enhanced sensitivity, and improved data quality – all while continuing to rely on your trusted system.

Get in touch to explore your ZetaView® upgrade options.
👉 https://www.particle-metrix.com/

28/01/2026

𝗣𝗮𝗿𝘁𝗶𝗰𝗹𝗲 𝗠𝗲𝘁𝗿𝗶𝘅 𝗮𝘁 𝘁𝗵𝗲 𝟯𝗿𝗱 “𝗧𝗶𝗻𝘆 𝗣𝗮𝗰𝗸𝗮𝗴𝗲𝘀 𝘄𝗶𝘁𝗵 𝗕𝗶𝗴 𝗜𝗺𝗽𝗮𝗰𝘁” 𝗪𝗼𝗿𝗸𝘀𝗵𝗼𝗽!

We’re excited to join the 3rd edition of the Tiny Packages with Big Impact Workshop on Extracellular Vesicles ( ), taking place February 7–11, 2026, at the University of Virginia.

Workshop highlights:
· Hands-on EV sessions in separation, counting, sizing, and imaging with real samples
· Expert-led lectures on the latest and translational applications
· Networking with leading researchers and industry professionals
· Short talks by industry representatives, including Particle Metrix (Feb 9, 11–11:30 am)
· Interactive, practical sessions, featuring a live demonstration of ZetaView® Evolution by Kevin Dolan and Dr. Sven Kreutel – see why it’s ideal for EV characterization (Feb 9, 1–4 pm)

We are delighted to showcase our innovative solutions in Charlottesville and contribute to advancing extracellular vesicle research.

23/01/2026

Day 1 at SelectBio Extracellular Vesicles Asia 2026 is almost over, a great start with inspiring discussions, sample measurements, and Rosa Jerlerud’s presentation.

Tomorrow the conference continues! Come visit the joint Particle Metrix - DKSH booth, where we showcase our ZetaView® Evolution for precise characterization of , , and biomolecular samples.

Already familiar with ?
Stop by anyway, we’d love to discuss your research and applications!

15/01/2026

Join Particle Metrix at SelectBio Extracellular Vesicles Asia 2026 in Shenzhen!

We are pleased to announce that Particle Metrix will be part of the SelectBIO Extracellular Vesicles 2026 Conference in Shenzhen—often referred to as the “Silicon Valley of China” for technology development.

Our team will be hosting a booth, where we will present our technology in partnership with our Chinese distributor, DKSH.
Visit us to learn how ZetaView® and our advanced Nanoparticle Tracking Analysis support EV research, biomarker discovery, and therapeutic development.
The conference brings together leading researchers and companies in and microfluidics, providing an excellent platform for scientific exchange and technology innovation.

We look forward to connecting with the community and discussing how Particle Metrix can support your work.

14/01/2026

𝗡𝗲𝘄 𝗖𝗼𝗼𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗟𝗶𝗽𝗶𝗱 & 𝗟𝗡𝗣 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵

RNA-based therapeutics hold immense potential to transform modern medicine due to their high safety profile, versatility, and rapid manufacturability.

However, naked or conventionally complexed mRNA is inherently unstable, requires high doses, exhibits poor cellular uptake, and shows limited endosomal escape. As a result, efficient systems are essential for successful in vitro, pre-clinical, and clinical applications. Among non-viral approaches, lipid nanoparticles ( ) have emerged as the most advanced and clinically validated platform for nucleic acid delivery, enabling effective protection, transport, and intracellular release of mRNA.

Against this backdrop, we are pleased to announce the start of a new this week with the Steinbeis-Innovationszentrum Zellkulturtechnik ( ) at Technische Hochschule Mannheim, led by Manfred Frey, CEO and Founder of the Center. We are very much looking forward to the scientific outcomes of this collaboration.

The SIZ project focuses on the development of novel, improved lipid nanoparticle formulations for delivery, with the goal of enhancing transfection efficiency in cell types that are typically difficult to transfect using conventional methods. Such advancements are critical for expanding the applicability of mRNA therapeutics across a broader range of cell models and disease indications.

We are especially excited that the Particle Metrix ZetaView® platform will play a central role in this work. It will be used for precise particle concentration and size analysis of the SIZ-LNP formulations, enabling comprehensive characterization in both scatter mode and fluorescence mode. This dual-mode analysis is of particular importance for correlating LNP physicochemical properties with functional performance, such as specific transfection activity. Accordingly, ZetaView® is employed by SIZ as an essential component of quality control throughout the formulation development process.

This collaboration is a strong example of how cutting-edge lipid and LNP formulation research can be seamlessly combined with advanced nanoparticle analytics to accelerate innovation in RNA therapeutics.

Steinbeis

12/01/2026

🔬 𝗣𝘂𝗯𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁 | 𝗭𝗲𝘁𝗮𝗩𝗶𝗲𝘄® 𝗤𝗨𝗔𝗧𝗧

A recent publication features the use of ZetaView® QUATT for the characterization of extracellular vesicles ( ) isolated from seminal plasma.
In the study, the authors optimized size-exclusion chromatography (SEC) and compared it with ultracentrifugation as an isolation method.
Nanoparticle Tracking Analysis ( ) using ZetaView® QUATT was applied to assess key EV parameters such as size and particle concentration.
In addition, zeta potential measurements were performed to gain insights into the functional integrity and biological efficacy of the EV samples.

If you would like to learn how SEC performs in comparison to ultracentrifugation, we invite you to explore the full publication and discover how ZetaView® QUATT enables reliable, high-quality, multi-parameter EV characterization.
🔗 https://doi.org/10.3390/biomedicines13102459

07/01/2026

Best wishes to our customers, partners, and colleagues for a successful 2026.

Thank you for your trust and collaboration in advancing Nanoparticle Tracking Analysis. We look forward to another year of discovery and innovation with the Particle Metrix technology platform.
See how ZetaView® Evolution can advance your research - contact us.
https://www.particle-metrix.com/pages/contact

Adresse

Wildmoos 4
Inning Am Ammersee
82266

Telefon

+498143991720

Webseite

https://www.particle-metrix.com/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Particle Metrix erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Verknüpfungen

Wollen Sie Ihr Praxis zum Top-Klinik in Inning am Ammersee machen?